中草药

免疫-线粒体-肠道微生态：绝经后骨质疏松症的多轴驱动机制及中医药整合干预

PDF下载

中草药 | 综述 2026,57(13): 5257-5272

收起

中草药 |综述 2026 , 57 (13) : 5257 -5272

免疫-线粒体-肠道微生态：绝经后骨质疏松症的多轴驱动机制及中医药整合干预

全屏

王霞霞¹, 梁永林¹, 朱向东^2,3, 白敏^2,3, 邵瑞雯¹, 景如歌¹, 杨彤¹, 安冬¹, 柳春¹

作者信息

通讯作者:

梁永林

作者简介:

王霞霞: 王霞霞，博士，从事中医药防治慢性骨病研究。E-mail:wxx15002543662@163.com

Immunity-mitochondria-gut microecology: Multi-axis driving mechanisms of postmenopausal osteoporosis and integrated intervention with traditional Chinese medicine

WANG Xiaxia, LIANG Yonglin, ZHU Xiangdong, BAI Min, SHAO Ruiwen, JING Ruge, YANG Tong, AN Dong, LIU Chun

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.13.027

文章导航

摘要

收起

绝经后骨质疏松症（postmenopausal osteoporosis，PMOP）是由雌激素缺乏所触发的慢性低度炎症、线粒体功能障碍导致的成骨损害与破骨激活，及肠道菌群失调引起的全身性炎症与代谢紊乱等多重病理机制共同驱动的结果。面对这一错综交织的多维病理网络，传统的单靶点治疗策略显示出明显局限。中医药凭借“整体观”和“辨证论治”的理论优势，展现出多靶点、多途径协同调控的系统性干预潜力。现有研究表明，多种中药复方及活性成分能够通过综合调节上述多维病理网络，有效恢复骨免疫微环境稳态、菌群与骨代谢平衡。系统综述了PMOP的多维作用机制，重点阐述了中医药在该病理网络中的多靶点调控作用，为深入解析PMOP病理机制、推动中西医融合的整合防治策略提供理论依据与研究思路。

关键词

绝经后骨质疏松 / 免疫炎症 / 线粒体功能障碍 / 肠道菌群 / 中医药

Abstract

收起

Postmenopausal osteoporosis (PMOP) results from a combination of multiple pathological mechanisms, including osteogenic impairment and osteoclast activation triggered by estrogen deficiency-induced chronic low-grade inflammation and mitochondrial dysfunction, as well as systemic inflammation and metabolic dysregulation caused by gut microbiota imbalance. Faced with this intricate and multidimensional pathological network, conventional single-target therapeutic strategies exhibit obvious limitations. Traditional Chinese medicine (TCM), with its theoretical advantages of “holistic view” and “syndrome differentiation-based treatment,” demonstrates potential for systematic intervention through multi-target and multi-pathway coordinated regulation. Current studies indicate that various TCM formulas and active components can effectively restore the homeostasis of the bone-immune microenvironment and balance between gut microbiota and bone metabolism by comprehensively modulating these multidimensional pathological networks. Based on this, this review systematically summarizes the multidimensional mechanisms of PMOP, highlighting the multi-target regulatory effects of TCM within this pathological network, thereby providing theoretical support and research ideas for in-depth elucidation of PMOP pathogenesis and for advancing integrated prevention and treatment strategies combining TCM and western medicine.

Key words

postmenopausal osteoporosis / immune-inflammation / mitochondrial dysfunction / gut microbiota / traditional Chinese medicine

引用本文

王霞霞, 梁永林, 朱向东, 白敏, 邵瑞雯, 景如歌, 杨彤, 安冬, 柳春. 免疫-线粒体-肠道微生态：绝经后骨质疏松症的多轴驱动机制及中医药整合干预. 中草药, 2026 , 57 (13) : 5257 -5272 . DOI: 10.7501/j.issn.0253-2670.2026.13.027

WANG Xiaxia, LIANG Yonglin, ZHU Xiangdong, BAI Min, SHAO Ruiwen, JING Ruge, YANG Tong, AN Dong, LIU Chun. Immunity-mitochondria-gut microecology: Multi-axis driving mechanisms of postmenopausal osteoporosis and integrated intervention with traditional Chinese medicine[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (13) : 5257 -5272 . DOI: 10.7501/j.issn.0253-2670.2026.13.027

基金

收起

国家自然科学基金资助项目 (82460897); 甘肃省自然科学基金资助项目 (24JRRA558); 甘肃省中医药研究中心专项开放课题 (zyzx-2024-zx01); 甘肃省高等学校产业支撑计划项目 (2021CYZC-03); 宁夏回族自治区II型糖尿病中医药态靶辨治基础与临床研究创新团队 (2022BSB03113); 甘肃省中医药研究中心专项开放课题 (zyzx-2025-zx08); 甘肃中医药大学研究生创新创业项目 (2026CXCY-208)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

杨子娴, 林青, 黄嘉家, 等. 中成药治疗绝经后骨质疏松症的系统评价再评价 [J]. 中草药, 2024, 55(12): 4121-4131.
Zhou G Y, Zhou Q R, Li R Y, et al. Synthetically engineered bacterial extracellular vesicles and IL-4-encapsulated hydrogels sequentially promote osteoporotic fracture repair [J]. ACS Nano, 2025, 19(16): 16064-16083.
Gehrke B, Alves Coelho M C, Brasil d’Alva C, et al. Long-term consequences of osteoporosis therapy with bisphosphonates [J]. Arch Endocrinol Metab, 2023, 68: e220334.
Klara J, Lewandowska-Łańcucka J. How efficient are alendronate-nano/biomaterial combinations for anti-osteoporosis therapy? An evidence-based review of the literature [J]. Int J Nanomed, 2022, 17: 6065-6094.
Ahmad John A, Xie J, Yang Y S, et al. AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy [J]. Mol Ther Nucleic Acids, 2022, 29: 296-311.
Sapra L, Saini C, Mishra P K, et al. Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “gut-immune-bone” axis [J]. Gut Microbes, 2025, 17(1): 2492378.
Wang X, Liu C J, Wang M Y, et al. Multi-modal microcarriers reprogram mitochondrial metabolism and activate efferocytosis in macrophages for osteoporotic bone repair [J]. Biomaterials, 2025, 322: 123384.
Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis [J]. Semin Cell Dev Biol, 2022, 123: 14-21.
Wu D, Cline-Smith A, Shashkova E, et al. T-cell mediated inflammation in postmenopausal osteoporosis [J]. Front Immunol, 2021, 12: 687551.
Yan Q Q, Liu H X, Zhu R Y, et al. Contribution of macrophage polarization in bone metabolism: A literature review [J]. Cytokine, 2024, 184: 156768.
Jiang L, He H D, Tang Y Y, et al. Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca²⁺ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy [J]. Autophagy, 2024, 20(11): 2388-2404.
Mendelsohn D H, Walter N, Cheung W H, et al. Targeting mitochondria in bone and cartilage diseases: A narrative review [J]. Redox Biol, 2025, 83: 103667.
He J, Chu Y N, Li J, et al. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis [J]. Sci Adv, 2022, 8(6): eabm1511.
Liu X F, Shao J H, Liao Y T, et al. Regulation of short-chain fatty acids in the immune system [J]. Front Immunol, 2023, 14: 1186892.
Hu M M, Shu H B. Mitochondrial DNA-triggered innate immune response: Mechanisms and diseases [J]. Cell Mol Immunol, 2023, 20(12): 1403-1412.
Candelli M, Franza L, Pignataro G, et al. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases [J]. Int J Mol Sci, 2021, 22(12): 6242.
Wastyk H C, Fragiadakis G K, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status [J]. Cell, 2021, 184(16): 4137-4153.
Wang B Y, Xiao L H, Chen P, et al. Uncovering the role of traditional Chinese medicine in immune-metabolic balance of gastritis from the perspective of cold and hot: Jin Hong Tablets as a case study [J]. Chin Med, 2024, 19(1): 134.
Shi Z X, Wang L P, Wang Z F, et al. Mitophagy and mitochondrial function regulation by traditional Chinese medicine small molecules in cancer therapy: Mechanisms, challenges, and translational opportunities [J]. Phytother Res, 2026, 40: 1290-1317.
Wang M, Fu R J, Xu D Q, et al. Traditional Chinese medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology [J]. J Ethnopharmacol, 2024, 318: 116879.
Händel M N, Cardoso I, von Bülow C, et al. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: Systematic review, network Meta-analysis, and Meta-regression analysis of randomised clinical trials [J]. BMJ, 2023, 381: e068033.
Bonaccorsi G, Rizzati M, Salani L, et al. Postmenopausal osteoporosis: Risk evaluation and treatment options [J]. Minerva Obstet Gynecol, 2021, 73(6): 714-729.
Rozenberg S, Di Pietrantonio V, Vandromme J, et al. Menopausal hormone therapy and breast cancer risk [J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(6): 101577.
Quattrini S, Pampaloni B, Gronchi G, et al. The Mediterranean diet in osteoporosis prevention: An insight in a peri- and post-menopausal population [J]. Nutrients, 2021, 13(2): 531.
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, et al. Current status of the diagnosis and management of osteoporosis [J]. Int J Mol Sci, 2022, 23(16): 9465.
Kistler-Fischbacher M, Weeks B K, Beck B R. The effect of exercise intensity on bone in postmenopausal women (part 2): A Meta-analysis [J]. Bone, 2021, 143: 115697.
Walker M D, Shane E. Postmenopausal osteoporosis [J]. N Engl J Med, 2023, 389(21): 1979-1991.
Jie Xu, Yu L X, Liu F, et al. The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: A review [J]. Front Immunol, 2023, 14: 1222129.
Kim J M, Lin C J, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis [J]. Cells, 2020, 9(9): 2073.
Tao H Q, Li W M, Zhang W, et al. Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways [J]. Pharmacol Res, 2021, 174: 105967.
Hao F Y, Guo M Y, Zhao Y W, et al. Qing’e Pills ameliorates osteoporosis by regulating gut microbiota and Th17/Treg balance in ovariectomized rats [J]. J Inflamm Res, 2025, 18: 7611-7629.
Yao Y, Cai X Y, Chen Y, et al. Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis [J]. Med Res Rev, 2025, 45(2): 561-575.
Wu S X, Ohba S, Matsushita Y. Single-cell RNA-sequencing reveals the skeletal cellular dynamics in bone repair and osteoporosis [J]. Int J Mol Sci, 2023, 24(12): 9814.
Zhang M Z, Liu Y L, Afzali H, et al. An update on periodontal inflammation and bone loss [J]. Front Immunol, 2024, 15: 1385436.
Ding P, Gao C, Zhou J, et al. Mitochondria from osteolineage cells regulate myeloid cell-mediated bone resorption [J]. Nat Commun, 2024, 15: 5094.
Frase D, Lee C, Nachiappan C, et al. The inflammatory contribution of B-lymphocytes and neutrophils in progression to osteoporosis [J]. Cells, 2023, 12(13): 1744.
Zhang S X, Zeng Y W, Zhang S X, et al. A metal-phenolic network-coated coacervate system mediates mitochondrial modulation and bone homeostasis restoration for postmenopausal osteoporosis therapy [J]. Nano Lett, 2025, 25(44): 15854-15863.
Gherardi G, Weiser A, Bermont F, et al. Mitochondrial calcium uptake declines during aging and is directly activated by oleuropein to boost energy metabolism and skeletal muscle performance [J]. Cell Metab, 2025, 37(2): 477-495.
Cai W J, Zhang J L, Yu Y Q, et al. Mitochondrial transfer regulates cell fate through metabolic remodeling in osteoporosis [J]. Adv Sci, 2023, 10(4): 2204871.
Li D L, Zhao Z H, Zhu L Y, et al. 7, 8-DHF inhibits BMSC oxidative stress via the TRKB/PI3K/Akt/Nrf2 pathway to improve symptoms of postmenopausal osteoporosis [J]. Free Radic Biol Med, 2024, 223: 413-429.
Fu Y Q, Meng L X, Zhang M L, et al. ED-71 alleviates OVX-induced osteoporosis by inhibiting macrophage senescence through SIRT1/PGC-1α pathway: A potential therapeutic approach [J]. Bone, 2026, 203: 117737.
Indrio F, Salatto A. Gut microbiota-bone axis [J]. Ann Nutr Metab, 2025, 81(Suppl 1): 47-56.
Ticinesi A, Siniscalchi C, Meschi T, et al. Gut microbiome and bone health: Update on mechanisms, clinical correlations, and possible treatment strategies [J]. Osteoporos Int, 2025, 36(2): 167-191.
Guan Z Y, Zheng X Q, Zhu J X, et al. Estrogen deficiency induces bone loss through the gut microbiota [J]. Pharmacol Res, 2023, 196: 106930.
Zhu C F, Zhang Y, Pan Y, et al. Clinical correlation between intestinal flora profiles and the incidence of postmenopausal osteoporosis [J]. Gynecol Endocrinol, 2025, 41(1): 2465587.
Zhang Y W, Cao M M, Li Y J, et al. Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function [J]. J Orthop Transl, 2022, 37: 46-60.
Lehmann J, Thiele S, Baschant U, et al. Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss [J]. iScience, 2021, 24(3): 102224.
Huang X Z, Ma J L, Wei Y K, et al. Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning [J]. Front Genet, 2023, 14: 1198417.
Azam Z, Sapra L, Baghel K, et al. Cissus quadrangularis (hadjod) inhibits RANKL-induced osteoclastogenesis and augments bone health in an estrogen-deficient preclinical model of osteoporosis via modulating the host osteoimmune system [J]. Cells, 2023, 12(2): 216.
Luo J, Li L, Shi W S, et al. Oxidative stress and inflammation: Roles in osteoporosis [J]. Front Immunol, 2025, 16: 1611932.
Ouyang L J, Li D, Li Z C, et al. IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals [J]. Front Psychiatry, 2022, 13: 1072380.
Astolfi-Labrador L, Cabezas-Corado Á, Torres-Lagares D, et al. Differences in inflammatory genetic profiles in periodontitis associated with genetic and immunological disorders: A systematic review [J]. Biomedicines, 2025, 13(12): 2851.
Yan W H, Li L, Ge L H, et al. The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition [J]. Stem Cell Res Ther, 2022, 13(1): 22.
Wang H, Ideguchi H, Kajikawa T, et al. Complement is required for microbe-driven induction of Th17 and periodontitis [J]. J Immunol, 2022, 209(7): 1370-1378.
Yu F X, Chang J, Li J L, et al. Protective effects of oridonin against osteoporosis by regulating immunity and activating the Wnt3a/β-catenin/VEGF pathway in ovariectomized mice [J]. Int Immunopharmacol, 2023, 118: 110011.
Guo M Y, Liu H J, Yu Y T, et al. Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure [J]. Gut Microbes, 2023, 15(1): 2190304.
Najar M, Rahmani S, Faour W H, et al. Umbilical cord mesenchymal stromal/stem cells and their interplay with Th-17 cell response pathway [J]. Cells, 2024, 13(2): 169.
Yang X S, Zhou F X, Yuan P Y, et al. T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg/Th17 balance [J]. Bioact Mater, 2021, 6(10): 3150-3163.
Zhu L, Hua F, Ding W G, et al. The correlation between the Th17/Treg cell balance and bone health [J]. Immun Ageing, 2020, 17(1): 30.
Peng P, Wong P, Lv Z, et al. Tectorigenin ameliorates glucocorticoid-induced osteoporosis by inhibiting the NF-κB signal pathway and modulating Treg-Th17 cell balance [J]. J Cell Mol Med, 2025, 29(13): e70705.
Yao Y, Cai X Y, Ren F J, et al. The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases [J]. Front Immunol, 2021, 12: 664871.
Wang Q, Peng X L, Xu H, et al. Narirutin mitigates inflammatory arthritis and osteoporosis through modulating macrophage phenotype and osteoclastogenesis [J]. J Orthop Transl, 2025, 54: 115-130.
Cutolo M, Campitiello R, Gotelli E, et al. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis [J]. Front Immunol, 2022, 13: 867260.
Wu K K, Xu X F, Wu M Y, et al. MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice [J]. Nat Commun, 2024, 15: 8624.
Zhang B, Yang Y, Yi J R, et al. Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis [J]. J Periodontal Res, 2021, 56(5): 991-1005.
Hsu C H, Pan Y J, Zheng Y T, et al. Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARγ signaling pathways [J]. CNS Neurosci Ther, 2023, 29(12): 4113-4123.
Cai G H, Lu Y H, Zhong W J, et al. Piezo1-mediated M2 macrophage mechanotransduction enhances bone formation through secretion and activation of transforming growth factor-β1 [J]. Cell Prolif, 2023, 56(9): e13440.
Deng Z B, Zhong W. CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation via NSUN5-mediated m5C modification [J]. Sci Rep, 2025, 15: 25246.
Borcherding N, Brestoff J R. The power and potential of mitochondria transfer [J]. Nature, 2023, 623(7986): 283-291.
Li J H, Lv M Q, Yuan Z J, et al. PGC-1α promotes mitochondrial biosynthesis and energy metabolism of goose fatty liver [J]. Poult Sci, 2025, 104(1): 104617.
Lacombe A, Scorrano L. The interplay between mitochondrial dynamics and autophagy: From a key homeostatic mechanism to a driver of pathology [J]. Semin Cell Dev Biol, 2024, 161: 1-19.
Zhang Y, Zhang H Y, Zhao F Q, et al. Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment [J]. Acta Pharm Sin B, 2023, 13(12): 5107-5120.
Liu J L, Gao Z H, Liu X J. Mitochondrial dysfunction and therapeutic perspectives in osteoporosis [J]. Front Endocrinol, 2024, 15: 1325317.
Yan C L, Shi Y, Yuan L Q, et al. Mitochondrial quality control and its role in osteoporosis [J]. Front Endocrinol, 2023, 14: 1077058.
Sabini E, Arboit L, Khan M P, et al. Oxidative phosphorylation in bone cells [J]. Bone Rep, 2023, 18: 101688.
Pal S, Porwal K, Rajak S, et al. Selective dietary polyphenols induce differentiation of human osteoblasts by adiponectin receptor 1-mediated reprogramming of mitochondrial energy metabolism [J]. Biomed Pharmacother, 2020, 127: 110207.
Wang W T, Wang Q, Li W M, et al. Targeting APJ drives BNIP3-PINK1-PARKIN induced mitophagy and improves systemic inflammatory bone loss [J]. J Adv Res, 2025, 76: 655-668.
Li W, Jiang W S, Su Y R, et al. PINK1/Parkin-mediated mitophagy inhibits osteoblast apoptosis induced by advanced oxidation protein products [J]. Cell Death Dis, 2023, 14(2): 88.
Lee S Y, An H J, Kim J M, et al. PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis [J]. Stem Cell Res Ther, 2021, 12(1): 589.
Wang Q, Liu J, Yang X M, et al. Gold nanoparticles enhance proliferation and osteogenic differentiation of periodontal ligament stem cells by PINK1-mediated mitophagy [J]. Arch Oral Biol, 2023, 150: 105692.
Zhou B L, Yuan Y T, Zhang S S, et al. Intestinal flora and disease mutually shape the regional immune system in the intestinal tract [J]. Front Immunol, 2020, 11: 575.
Chopyk D M, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders [J]. Gastroenterology, 2020, 159(3): 849-863.
Kverka M, Stepan J J. Associations among estrogens, the gut microbiome and osteoporosis [J]. Curr Osteoporos Rep, 2024, 23(1): 2.
Song C H, Ma Y J, Wang Y H, et al. Diosgenin reduces bone loss through the regulation of gut microbiota in ovariectomized rats [J]. Gene, 2023, 869: 147383.
Kermgard E, Chawla N K, Wesseling-Perry K. Gut microbiome, parathyroid hormone, and bone [J]. Curr Opin Nephrol Hypertens, 2021, 30(4): 418-423.
Yang K L, Mullins B J, Lejeune A, et al. Mitigation of osteoclast-mediated arthritic bone remodeling by short chain fatty acids [J]. Arthritis Rheumatol, 2024, 76(4): 647-659.
Lucas S, Omata Y, Hofmann J, et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss [J]. Nat Commun, 2018, 9: 55.
Wang J L, Wu S, Zhang Y S, et al. Gut microbiota and calcium balance [J]. Front Microbiol, 2022, 13: 1033933.
Barrea L, Verde L, Auriemma R S, et al. Probiotics and prebiotics: Any role in menopause-related diseases? [J]. Curr Nutr Rep, 2023, 12(1): 83-97.
Shepherd R, Cheung A S, Pang K, et al. Sexual dimorphism in innate immunity: The role of sex hormones and epigenetics [J]. Front Immunol, 2021, 11: 604000.
Kim S, Lee J Y, Shin S G, et al. ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota [J]. Autophagy, 2021, 17(10): 2856-2875.
Zhu Y, Fang Z Q, Bai J, et al. Orally administered functional polyphenol-nanozyme-armored probiotics for enhanced amelioration of intestinal inflammation and microbiota dysbiosis [J]. Adv Sci, 2025, 12(17): 2411939.
Yin K, Wang D X, Zhang Y, et al. Polystyrene microplastics promote liver inflammation by inducing the formation of macrophages extracellular traps [J]. J Hazard Mater, 2023, 452: 131236.
Patoli D, Mignotte F, Deckert V, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis [J]. J Clin Invest, 2020, 130(11): 5858-5874.
Guo C L, Guo D D, Fang L, et al. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon [J]. Carbohydr Polym, 2021, 267: 118231.
Marques-Carvalho A, Kim H N, Almeida M. The role of reactive oxygen species in bone cell physiology and pathophysiology [J]. Bone Rep, 2023, 19: 101664.
San-Millan I, Sparagna G C, Chapman H L, et al. Chronic lactate exposure decreases mitochondrial function by inhibition of fatty acid uptake and cardiolipin alterations in neonatal rat cardiomyocytes [J]. Front Nutr, 2022, 9: 809485.
Yang L, Liu X F, Chen S Y, et al. Scutellarin ameliorates mitochondrial dysfunction and apoptosis in OGD/R-insulted HT₂₂ cells through mitophagy induction [J]. Biomed Pharmacother, 2024, 179: 117340.
He Y J, Li Z, Xu T, et al. Polystyrene nanoplastics deteriorate LPS-modulated duodenal permeability and inflammation in mice via ROS drived-NF-κB/NLRP3 pathway [J]. Chemosphere, 2022, 307(Pt1): 135662.
Zhang Y, Yin K, Wang D X, et al. Polystyrene microplastics-induced cardiotoxicity in chickens via the ROS-driven NF-κB-NLRP3-GSDMD and AMPK-PGC-1α axes [J]. Sci Total Environ, 2022, 840: 156727.
Chen C, Cao Z, Lei H H, et al. Microbial tryptophan metabolites ameliorate ovariectomy-induced bone loss by repairing intestinal AhR-mediated gut-bone signaling pathway [J]. Adv Sci, 2024, 11(36): 2404545.
Di Vincenzo F, Del Gaudio A, Petito V, et al. Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review [J]. Intern Emerg Med, 2024, 19(2): 275-293.
Chen W J, Wang X L, Wang Y F, et al. LPL-RH suppresses bone loss in ovariectomised rat models [J]. BMC Microbiol, 2024, 24(1): 545.
Neurath M F, Artis D, Becker C. The intestinal barrier: A pivotal role in health, inflammation, and cancer [J]. Lancet Gastroenterol Hepatol, 2025, 10(6): 573-592.
Mao N N, Yu Y M, Lu X Q, et al. Preventive effects of matrine on LPS-induced inflammation in RAW264.7 cells and intestinal damage in mice through the TLR4/NF-κB/MAPK pathway [J]. Int Immunopharmacol, 2024, 143(Pt 2): 113432.
Wang Y, Wang Y C, Ma J, et al. YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice [J]. J Ethnopharmacol, 2023, 312: 116452.
Grylls A, Seidler K, Neil J. Link between microbiota and hypertension: Focus on LPS/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics [J]. Biomed Pharmacother, 2021, 137: 111334.
Chen F, Chu C N, Wang X Y, et al. Hesperetin attenuates sepsis-induced intestinal barrier injury by regulating neutrophil extracellular trap formation via the ROS/ autophagy signaling pathway [J]. Food Funct, 2023, 14(9): 4213-4227.
Zhou N, Gu T T, Duan M C, et al. Gut microbiota dysbiosis exacerbates polystyrene microplastics-induced liver inflammation via activating LPS/TLR4 signaling pathway in ducks [J]. Poult Sci, 2025, 104(11): 105757.
Wu G F, Nie W B, Wang Q, et al. Umbelliferone ameliorates complete Freund adjuvant–induced arthritis via reduction of NF-κB signaling pathway in osteoclast differentiation [J]. Inflammation, 2021, 44(4): 1315-1329.
Zhao Y K, Li H, Guo Y Y. Interleukin family in vascular calcification: Molecular mechanisms and therapeutic perspectives [J]. Front Cardiovasc Med, 2025, 12: 1619018.
Ni C Y, Wang L P, Bai Y Y, et al. Taurochenodeoxycholic acid activates autophagy and suppresses inflammatory responses in microglia of MPTP-induced Parkinson’s disease mice via AMPK/mTOR, Akt/NFκB and Pink1/ Parkin signaling pathways mediated by Takeda G protein-coupled receptor 5 [J]. Free Radic Biol Med, 2025, 235: 347-363.
Diaz D, Lopez-Dolado E, Haro S, et al. Systemic inflammation and the breakdown of intestinal homeostasis are key events in chronic spinal cord injury patients [J]. Int J Mol Sci, 2021, 22(2): 744.
Zhang P, Zhang D F, Zhou W A, et al. Network pharmacology: Towards the artificial intelligence-based precision traditional Chinese medicine [J]. Brief Bioinform, 2023, 25(1): bbad518.
Liu H T, Zheng J P, Lai H C, et al. Microbiome technology empowers the development of traditional Chinese medicine [J]. Sci China Life Sci, 2020, 63(11): 1759-1761.
Wang K J, Yin J, Chen J Y, et al. Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis [J]. Phytomedicine, 2024, 128: 155258.
白蕊, 李卫红, 陈迷, 等. 壮骨方调控巨噬细胞M1/M2型极化对绝经后骨质疏松症大鼠破骨细胞分化的影响 [J]. 时珍国医国药, 2025, 36(23): 4444-4451.
颜春鲁, 石杨洋, 宋佳眙, 等. 藤黄健骨胶囊通过调控TNF-α/IL-6/JAK2/STAT3通路抑制肾虚血瘀型绝经后骨质疏松患者Th17细胞分化的机制研究 [J]. 中国现代应用药学, 2025, 42(14): 2445-2452.
谢宝华, 赵霖, 朱肖肖, 等. 左归丸对绝经后骨质疏松妇女Th17/Treg亚群偏移的影响 [J]. 济宁医学院学报, 2019, 42(3): 166-170.
曾英, 李伟娟, 章文娟, 等. 壮骨止痛胶囊对去卵巢骨质疏松大鼠骨组织Treg/Th17平衡的调节作用 [J]. 北京中医药大学学报, 2016, 39(7): 555-561.
蒋红. 续苓健骨方对骨质疏松模型大鼠Treg/Th17细胞分化及其相关因子的作用研究 [D]. 福州: 福建中医药大学, 2023.
叶枝茂, 惠久莹, 钟晓霞, 等. 罗汉果苷V调控高糖状态巨噬细胞M1极化促进骨髓间充质干细胞的成骨分化 [J]. 中国组织工程研究, 2025, 29(19): 3968-3975.
龙隆海. 黄芩苷通过巨噬细胞M2极化促进骨髓间充质干细胞成骨分化的机制研究 [D]. 泸州: 西南医科大学, 2024.
Wang N, Yang H, Tong X, et al. Ginkgolide B modulates the gut-bone axis to ameliorate bone loss in ovariectomized mice [J]. J Orthop Surg Res, 2025, 20(1): 804.
王斌, 董洪洋, 高松, 等. 积雪草酸调节Treg/Th17平衡和肠道菌群改善卵巢切除小鼠骨质疏松症 [J]. 中国优生与遗传杂志, 2025, 33(2): 253-259.
宋敏, 文皓楠, 宋永嘉, 等. 固本增骨胶囊对绝经后骨质疏松大鼠骨组织氧化应激介导的线粒体途径凋亡及骨代谢的干预作用 [J]. 中国中药杂志, 2025, 50(23): 6721-6730.
杨莹, 冯秀芝, 陈怡然, 等. 左、右归丸干预PGC-1α/ PPARγ对骨髓间充质干细胞线粒体生物发生的影响 [J]. 中国实验方剂学杂志, 2025, 31(9): 28-36.
Li J Y, Zhang D H, Zhang Y X, et al. Mitochondria‐specific antioxidant mitoTEMPO alleviates senescence of bone marrow mesenchymal stem cells in ovariectomized rats [J]. J Cell Physiol, 2024, 239(8): e31323.
Li M Y, Yu Y J, Xue K, et al. Genistein mitigates senescence of bone marrow mesenchymal stem cells via ERRα-mediated mitochondrial biogenesis and mitophagy in ovariectomized rats [J]. Redox Biol, 2023, 61: 102649.
Yang T, Chen W W, Gan K, et al. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis [J]. J Transl Med, 2023, 21(1): 839.
于冬冬, 陈奎竹, 郭强, 等. 基于“肠道菌群”探讨龟鹿二仙胶防治绝经后骨质疏松症的机制 [J]. 中华中医药学刊, 2025, 43(6): 5-8.
韩京辰, 廖建晖, 吴官保, 等. 补肾活血汤对去势骨质疏松大鼠TLR4/MyD88/NF-κB信号通路及肠道菌群的影响 [J]. 时珍国医国药, 2024, 35(5): 1127-1131.
李宁, 吴月滢, 裴环, 等. 基于“肠-骨”轴探讨药食同源复方强骨宁缓解绝经后骨质疏松症的作用机制 [J]. 中华中医药杂志, 2024, 39(5): 2308-2315.
卓嘉璐, 李子祥, 杨宁, 等. 枸杞多糖对绝经后骨质疏松患者肠道菌群结构及短链脂肪酸的影响 [J]. 微循环学杂志, 2023, 33(4): 27-34.
Feng R B, Wang Q, Yu T T, et al. Quercetin ameliorates bone loss in OVX rats by modulating the intestinal flora-SCFAs-inflammatory signaling axis [J]. Int Immunopharmacol, 2024, 136: 112341.
郑修竹, 朱春雨, 梁彦博, 等. 冬凌草甲素对绝经后骨质疏松小鼠肠道菌群的影响 [J]. 中国骨质疏松杂志, 2025, 31(6): 799-805.
Li X Y, Xue C H, Yang Y M, et al. Therapeutic effects of Isaria felina on postmenopausal osteoporosis: Modulation of gut microbiota, metabolites, and immune responses [J]. Front Immunol, 2025, 16: 1508634.

2026年第57卷第13期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.13.027

接收时间：2026-02-06
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-02-06

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.13.027

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT